TOMSICEK MICHAEL JOHN 4
4 · Acrivon Therapeutics, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
TOMSICEK MICHAEL JOHN
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-11-14+35,235→ 35,235 totalExercise: $12.50Exp: 2032-11-13→ Common Stock (35,235 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 36 equal monthly installments beginning on October 12, 2022 ("Vesting Commencement Date"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date.